Alpine Global Management’s Biogen BIIB Stock Holding History

Alpine Global Management’s Portfolio BIIB Stock Details BIIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-2,788	Closed	-$669K	–	474
2021 Q4	$669K	Buy	+2,788	New	+$717K	0.1%	255
2020 Q3	–	Sell	-1,929	Closed	-$516K	–	253
2020 Q2	$516K	Buy	+1,929	New	+$580K	0.09%	139
2020 Q1	–	Sell	-12,665	Closed	-$3.76M	–	251
2019 Q4	$3.76M	Buy	+12,665	New	+$3.51M	0.8%	22
2017 Q4	–	Sell	-1,541	Closed	-$483K	–	195
2017 Q3	$483K	Buy	+1,541	New	+$456K	0.14%	106
2017 Q2	–	Sell	-1,370	Closed	-$375K	–	149
2017 Q1	$375K	Buy	+1,370	New	+$387K	0.1%	174
2015 Q3	–	Sell	-1,064	Closed	-$430K	–	176
2015 Q2	$430K	Sell	1,064 -88	-8%	-$35.3K	0.07%	200
2015 Q1	$486K	Sell	1,152 -3,742	-76%	-$1.47M	0.16%	140
2014 Q4	$1.66M	Buy	+4,894	New	+$1.58M	0.3%	83

Other funds holding BIIB

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Legal & General Group London, United Kingdom $480B AUM 42.84% 1-Year Est. Return

Alpine Global Management's BIIB Position: Q1 2022 in Review

Alpine Global Management sold out of Biogen (BIIB) in Q1 2022, closing a stake of 2,788 shares — an estimated $669K sold.

Alpine Global Management first reported a position in BIIB in Q4 2014 and held it in 8 quarters. The position peaked at $3.76M in Q4 2019. 951 funds tracked by Wall St. Rank hold BIIB as of Q1 2022.

Alpine Global Management reported no remaining Biogen position as of Q1 2022 after selling out during the quarter.
Alpine Global Management sold 2,788 Biogen shares in Q1 2022, an estimated $669K.
Alpine Global Management first reported a position in Biogen in Q4 2014 and held it in 8 quarters.
Alpine Global Management's Biogen position peaked at $3.76M in Q4 2019.
951 funds tracked by Wall St. Rank held Biogen as of Q1 2022.

Based on Alpine Global Management's 13F filing for Q1 2022, filed 13 May 2022.